-
1
-
-
34248204113
-
Airway smooth muscle dynamics: a common pathway of airway obstruction in asthma
-
An S. Bai T. Bates J. Black J. Brown R. Brusasco V. et al. (2007) Airway smooth muscle dynamics: a common pathway of airway obstruction in asthma. Eur Respir J 29: 834–860.
-
(2007)
Eur Respir J
, vol.29
, pp. 834-860
-
-
An, S.1
Bai, T.2
Bates, J.3
Black, J.4
Brown, R.5
Brusasco, V.6
-
2
-
-
77951962428
-
Inhibition of neutrophil elastase-induced goblet cell metaplasia by tiotropium in mice
-
Arai N. Kondo M. Izumo T. Tamaoki J. Nagai A. (2010) Inhibition of neutrophil elastase-induced goblet cell metaplasia by tiotropium in mice. Eur Respir J 35: 1164–1171.
-
(2010)
Eur Respir J
, vol.35
, pp. 1164-1171
-
-
Arai, N.1
Kondo, M.2
Izumo, T.3
Tamaoki, J.4
Nagai, A.5
-
4
-
-
79952056758
-
Tiotropium bromide inhibits TGF-beta-induced MMP production from lung fibroblasts by interfering with Smad and MAPK pathways in vitro
-
Asano K. Shikama Y. Shoji N. Hirano K. Suzaki H. Nakajima H. (2010) Tiotropium bromide inhibits TGF-beta-induced MMP production from lung fibroblasts by interfering with Smad and MAPK pathways in vitro. Int J Chron Obstruct Pulmon Dis 5: 277–286.
-
(2010)
Int J Chron Obstruct Pulmon Dis
, vol.5
, pp. 277-286
-
-
Asano, K.1
Shikama, Y.2
Shoji, N.3
Hirano, K.4
Suzaki, H.5
Nakajima, H.6
-
5
-
-
79960973276
-
Tiotropium is noninferior to salmeterol in maintaining improved lung function in B16-Arg/Arg patients with asthma
-
Bateman E. Kornmann O. Schmidt P. Pivovarova A. Engel M. Fabbri L. (2011) Tiotropium is noninferior to salmeterol in maintaining improved lung function in B16-Arg/Arg patients with asthma. J Allergy Clin Immunol 128: 315–322.
-
(2011)
J Allergy Clin Immunol
, vol.128
, pp. 315-322
-
-
Bateman, E.1
Kornmann, O.2
Schmidt, P.3
Pivovarova, A.4
Engel, M.5
Fabbri, L.6
-
6
-
-
27644530096
-
Cholinergic pathways in the lungs and anticholinergic therapy for chronic obstructive pulmonary disease
-
discussion 311–312.
-
Belmonte K. (2005) Cholinergic pathways in the lungs and anticholinergic therapy for chronic obstructive pulmonary disease. Proc Am Thorac Soc 2: 297–304; discussion 311–312.
-
(2005)
Proc Am Thorac Soc
, vol.2
, pp. 297-304
-
-
Belmonte, K.1
-
7
-
-
38449113726
-
Inhibition of allergen-induced airway remodelling by tiotropium and budesonide: a comparison
-
Bos I. Gosens R. Zuidhof A. Schaafsma D. Halayko A. Meurs H. et al. (2007) Inhibition of allergen-induced airway remodelling by tiotropium and budesonide: a comparison. Eur Respir J 30: 653–661.
-
(2007)
Eur Respir J
, vol.30
, pp. 653-661
-
-
Bos, I.1
Gosens, R.2
Zuidhof, A.3
Schaafsma, D.4
Halayko, A.5
Meurs, H.6
-
8
-
-
0038366897
-
Health outcomes following treatment for six months with once daily tiotropium compared with twice daily salmeterol i1n patients with COPD
-
Brusasco V. Hodder R. Miravitlles M. Korducki L. Towse L. Kesten S. (2003) Health outcomes following treatment for six months with once daily tiotropium compared with twice daily salmeterol i1n patients with COPD. Thorax 58: 399–404.
-
(2003)
Thorax
, vol.58
, pp. 399-404
-
-
Brusasco, V.1
Hodder, R.2
Miravitlles, M.3
Korducki, L.4
Towse, L.5
Kesten, S.6
-
9
-
-
84857089767
-
Non-bronchodilating mechanisms of tiotropium prevent airway hyperreactivity in a guinea pig model of allergic asthma
-
Buels K. Jacoby D. Fryer A. (2012) Non-bronchodilating mechanisms of tiotropium prevent airway hyperreactivity in a guinea pig model of allergic asthma. Br J Pharmacol 165: 1501–1514.
-
(2012)
Br J Pharmacol
, vol.165
, pp. 1501-1514
-
-
Buels, K.1
Jacoby, D.2
Fryer, A.3
-
10
-
-
34748819974
-
Tiotropium suppresses acetylcholine-induced release of chemotactic mediators in vitro
-
Buhling F. Lieder N. Kuhlmann U. Waldburg N. Welte T. (2007) Tiotropium suppresses acetylcholine-induced release of chemotactic mediators in vitro. Respir Med 101: 2386–2394.
-
(2007)
Respir Med
, vol.101
, pp. 2386-2394
-
-
Buhling, F.1
Lieder, N.2
Kuhlmann, U.3
Waldburg, N.4
Welte, T.5
-
11
-
-
0036181956
-
A long-term evaluation of once-daily inhaled tiotropium in chronic obstructive pulmonary disease
-
Casaburi R. Mahler D.A. Jones P.W. Wanner A. San P.G. ZuWallack R.L. et al. (2002) A long-term evaluation of once-daily inhaled tiotropium in chronic obstructive pulmonary disease. Eur Respir J 19: 217–224.
-
(2002)
Eur Respir J
, vol.19
, pp. 217-224
-
-
Casaburi, R.1
Mahler, D.A.2
Jones, P.W.3
Wanner, A.4
San, P.G.5
ZuWallack, R.L.6
-
12
-
-
0033663165
-
MMP-2- and MMP-9-linked gelatinolytic activity in the sputum from patients with asthma and chronic obstructive pulmonary disease
-
Cataldo D. Munaut C. Noel A. Frankenne F. Bartsch P. Foidart J. et al. (2000) MMP-2- and MMP-9-linked gelatinolytic activity in the sputum from patients with asthma and chronic obstructive pulmonary disease. Int Arch Allergy Immunol 123: 259–267.
-
(2000)
Int Arch Allergy Immunol
, vol.123
, pp. 259-267
-
-
Cataldo, D.1
Munaut, C.2
Noel, A.3
Frankenne, F.4
Bartsch, P.5
Foidart, J.6
-
15
-
-
78049265848
-
Aclidinium bromide abrogates allergen-induced hyperresponsiveness and reduces eosinophilia in murine model of airway inflammation
-
Damera G. Jiang M. Zhao H. Fogle H. Jester W. Freire J. et al. (2010) Aclidinium bromide abrogates allergen-induced hyperresponsiveness and reduces eosinophilia in murine model of airway inflammation. Eur J Pharmacol 649: 349–353.
-
(2010)
Eur J Pharmacol
, vol.649
, pp. 349-353
-
-
Damera, G.1
Jiang, M.2
Zhao, H.3
Fogle, H.4
Jester, W.5
Freire, J.6
-
16
-
-
39149107800
-
Proliferative actions of muscarinic receptors expressed in macrophages derived from normal and tumor bearing mice
-
de la Torre E. Genaro A. Ribeiro M. Pagotto R. Pignataro O. Sales M. (2008) Proliferative actions of muscarinic receptors expressed in macrophages derived from normal and tumor bearing mice. Biochim Biophys Acta 1782: 82–89.
-
(2008)
Biochim Biophys Acta
, vol.1782
, pp. 82-89
-
-
de la Torre, E.1
Genaro, A.2
Ribeiro, M.3
Pagotto, R.4
Pignataro, O.5
Sales, M.6
-
17
-
-
84871396857
-
Comparative safety of inhaled medications in patients with chronic obstructive pulmonary disease: systematic review and mixed treatment comparison meta-analysis of randomised controlled trials
-
Dong Y. Lin H. Shau W. Wu Y. Chang C. Lai M. (2013) Comparative safety of inhaled medications in patients with chronic obstructive pulmonary disease: systematic review and mixed treatment comparison meta-analysis of randomised controlled trials. Thorax 68: 48–56.
-
(2013)
Thorax
, vol.68
, pp. 48-56
-
-
Dong, Y.1
Lin, H.2
Shau, W.3
Wu, Y.4
Chang, C.5
Lai, M.6
-
18
-
-
82755190518
-
Efficacy and safety of once-daily NVA 237 in patients with moderate-to-severe COPD: the GLOW 1 trial
-
D'Urzo A. Ferguson G. van Noord J. Hirata K. Martin C. Horton R. et al. (2011) Efficacy and safety of once-daily NVA 237 in patients with moderate-to-severe COPD: the GLOW 1 trial. Respir Res 12: 156.
-
(2011)
Respir Res
, vol.12
, pp. 156
-
-
D'Urzo, A.1
Ferguson, G.2
van Noord, J.3
Hirata, K.4
Martin, C.5
Horton, R.6
-
19
-
-
34247645201
-
A proof of concept study to evaluate stepping down the dose of fluticasone in combination with salmeterol and tiotropium in severe persistent asthma
-
Fardon T. Haggart K. Lee D. Lipworth B. (2007) A proof of concept study to evaluate stepping down the dose of fluticasone in combination with salmeterol and tiotropium in severe persistent asthma. Respir Med 101: 1218–1228.
-
(2007)
Respir Med
, vol.101
, pp. 1218-1228
-
-
Fardon, T.1
Haggart, K.2
Lee, D.3
Lipworth, B.4
-
20
-
-
70350462573
-
Characterization of aclidinium bromide, a novel inhaled muscarinic antagonist, with long duration of action and a favorable pharmacological profile
-
Gavaldà A. Miralpeix M. Ramos I. Otal R. Carreno C. Vinals M. et al. (2009) Characterization of aclidinium bromide, a novel inhaled muscarinic antagonist, with long duration of action and a favorable pharmacological profile. J Pharmacol Exp Ther 331: 740–751.
-
(2009)
J Pharmacol Exp Ther
, vol.331
, pp. 740-751
-
-
Gavaldà, A.1
Miralpeix, M.2
Ramos, I.3
Otal, R.4
Carreno, C.5
Vinals, M.6
-
21
-
-
84898864862
-
Global Initiative for Asthma (update 2012)
-
GINA Available at
-
GINA (2012) Global Initiative for Asthma (update 2012). Available at: http://www.ginaasthma.org.
-
(2012)
-
-
-
23
-
-
18644380685
-
Protective effects of tiotropium bromide in the progression of airway smooth muscle remodeling
-
Gosens R. Bos I. Zaagsma J. Meurs H. (2005) Protective effects of tiotropium bromide in the progression of airway smooth muscle remodeling. Am J Respir Crit Care Med 171: 1096–1102.
-
(2005)
Am J Respir Crit Care Med
, vol.171
, pp. 1096-1102
-
-
Gosens, R.1
Bos, I.2
Zaagsma, J.3
Meurs, H.4
-
24
-
-
73249148900
-
Muscarinic M 3 receptor stimulation increases cigarette smoke-induced IL-8 secretion by human airway smooth muscle cells
-
Gosens R. Rieks D. Meurs H. Ninaber D. Rabe K. Nanninga J. et al. (2009) Muscarinic M 3 receptor stimulation increases cigarette smoke-induced IL-8 secretion by human airway smooth muscle cells. Eur Respir J 34: 1436–1443.
-
(2009)
Eur Respir J
, vol.34
, pp. 1436-1443
-
-
Gosens, R.1
Rieks, D.2
Meurs, H.3
Ninaber, D.4
Rabe, K.5
Nanninga, J.6
-
25
-
-
33745218112
-
Muscarinic receptor signaling in the pathophysiology of asthma and COPD
-
Gosens R. Zaagsma J. Meurs H. Halayko A. (2006) Muscarinic receptor signaling in the pathophysiology of asthma and COPD. Respir Res 7: 73.
-
(2006)
Respir Res
, vol.7
, pp. 73
-
-
Gosens, R.1
Zaagsma, J.2
Meurs, H.3
Halayko, A.4
-
26
-
-
58149376396
-
Muscarinic receptors mediate stimulation of collagen synthesis in human lung fibroblasts
-
Haag S. Matthiesen S. Juergens U. Racke K. (2008) Muscarinic receptors mediate stimulation of collagen synthesis in human lung fibroblasts. Eur Respir J 32: 555–562.
-
(2008)
Eur Respir J
, vol.32
, pp. 555-562
-
-
Haag, S.1
Matthiesen, S.2
Juergens, U.3
Racke, K.4
-
27
-
-
66549116089
-
Patient-level pooled analysis of the effect of tiotropium on COPD exacerbations and related hospitalisations
-
Halpin D. Menjoge S. Viel K. (2009) Patient-level pooled analysis of the effect of tiotropium on COPD exacerbations and related hospitalisations. Prim Care Respir J 18: 106–113.
-
(2009)
Prim Care Respir J
, vol.18
, pp. 106-113
-
-
Halpin, D.1
Menjoge, S.2
Viel, K.3
-
28
-
-
2942720573
-
The nature of small-airway obstruction in chronic obstructive pulmonary disease
-
Hogg J. Chu F. Utokaparch S. Woods R. Elliott W. Buzatu L. et al. (2004) The nature of small-airway obstruction in chronic obstructive pulmonary disease. N Engl J Med 350: 2645–2653.
-
(2004)
N Engl J Med
, vol.350
, pp. 2645-2653
-
-
Hogg, J.1
Chu, F.2
Utokaparch, S.3
Woods, R.4
Elliott, W.5
Buzatu, L.6
-
31
-
-
0027232088
-
Human eosinophil major basic protein is an endogenous allosteric antagonist at the inhibitory muscarinic M 2 receptor
-
Jacoby D. Gleich G. Fryer A. (1993) Human eosinophil major basic protein is an endogenous allosteric antagonist at the inhibitory muscarinic M 2 receptor. J Clin Invest 91: 1314–1318.
-
(1993)
J Clin Invest
, vol.91
, pp. 1314-1318
-
-
Jacoby, D.1
Gleich, G.2
Fryer, A.3
-
32
-
-
70349146860
-
Airway smooth muscle thickness in asthma is related to severity but not duration of asthma
-
James A. Bai T. Mauad T. Abramson M. Dolhnikoff M. McKay K. et al. (2009) Airway smooth muscle thickness in asthma is related to severity but not duration of asthma. Eur Respir J 34: 1040–1045.
-
(2009)
Eur Respir J
, vol.34
, pp. 1040-1045
-
-
James, A.1
Bai, T.2
Mauad, T.3
Abramson, M.4
Dolhnikoff, M.5
McKay, K.6
-
33
-
-
70349513461
-
Safety and pharmacokinetics of multiple doses of aclidinium bromide, a novel long-acting muscarinic antagonist for the treatment of chronic obstructive pulmonary disease, in healthy participants
-
Jansat J. Lamarca R. de Miquel G. Schrodter A. Miletzki B. Gurniak M. (2009) Safety and pharmacokinetics of multiple doses of aclidinium bromide, a novel long-acting muscarinic antagonist for the treatment of chronic obstructive pulmonary disease, in healthy participants. J Clin Pharmacol 49: 1239–1246.
-
(2009)
J Clin Pharmacol
, vol.49
, pp. 1239-1246
-
-
Jansat, J.1
Lamarca, R.2
de Miquel, G.3
Schrodter, A.4
Miletzki, B.5
Gurniak, M.6
-
34
-
-
0035891664
-
Remodeling in asthma and chronic obstructive lung disease
-
Jeffery P. (2001) Remodeling in asthma and chronic obstructive lung disease. Am J Respir Crit Care Med 164: S28–S38.
-
(2001)
Am J Respir Crit Care Med
, vol.164
, pp. S28-S38
-
-
Jeffery, P.1
-
36
-
-
77952289988
-
Bronchodilatory effects of aclidinium bromide, a long-acting muscarinic antagonist, in COPD patients
-
Joos G. Schelfhout V. Pauwels R. Kanniess F. Magnussen H. Lamarca R. et al. (2010) Bronchodilatory effects of aclidinium bromide, a long-acting muscarinic antagonist, in COPD patients. Respir Med 104: 865–872.
-
(2010)
Respir Med
, vol.104
, pp. 865-872
-
-
Joos, G.1
Schelfhout, V.2
Pauwels, R.3
Kanniess, F.4
Magnussen, H.5
Lamarca, R.6
-
37
-
-
84866439937
-
Tiotropium versus placebo for chronic obstructive pulmonary disease
-
CD009285.
-
Karner C. Chong J. Poole P. (2012) Tiotropium versus placebo for chronic obstructive pulmonary disease. Cochrane Database Syst Rev 7: CD009285.
-
(2012)
Cochrane Database Syst Rev
, vol.7
-
-
Karner, C.1
Chong, J.2
Poole, P.3
-
38
-
-
33645679788
-
Cholinergic receptor and cyclic stretch-mediated inflammatory gene expression in intact ASM
-
Kanefsky J. Lenburg M. Hai C. (2006) Cholinergic receptor and cyclic stretch-mediated inflammatory gene expression in intact ASM. Am J Respir Cell Mol Biol 34: 417–425.
-
(2006)
Am J Respir Cell Mol Biol
, vol.34
, pp. 417-425
-
-
Kanefsky, J.1
Lenburg, M.2
Hai, C.3
-
39
-
-
0037212314
-
Role of matrix metalloproteinases in asthma
-
Kelly E. Jarjour N. (2003) Role of matrix metalloproteinases in asthma. Curr Opin Pulm Med 9: 28–33.
-
(2003)
Curr Opin Pulm Med
, vol.9
, pp. 28-33
-
-
Kelly, E.1
Jarjour, N.2
-
42
-
-
84859305834
-
for the ACCORD I study investigators
-
Efficacy and safety of a 12-week treatment with twice-daily aclidinium bromide in COPD patients (ACCORD COPD I)
-
Kerwin E. D'Urzo A. Gelb A. Lakkis H. Garcia Gil E. Caracta C., for the ACCORD I study investigators (2012 a) Efficacy and safety of a 12-week treatment with twice-daily aclidinium bromide in COPD patients (ACCORD COPD I). COPD 9: 90–101.
-
(2012)
COPD
, vol.9
, pp. 90-101
-
-
Kerwin, E.1
D'Urzo, A.2
Gelb, A.3
Lakkis, H.4
Garcia Gil, E.5
Caracta, C.6
-
43
-
-
84868554172
-
Efficacy and safety of NVA 237 versus placebo and tiotropium in patients with moderate-to-severe COPD over 52 weeks: The GLOW 2 study
-
Kerwin E. Hebert J. Gallagher N. Martin C. Overend T. Alagappan V.K. et al. (2012 b) Efficacy and safety of NVA 237 versus placebo and tiotropium in patients with moderate-to-severe COPD over 52 weeks: The GLOW 2 study. Eur Respir J 40: 1106–1114.
-
(2012)
Eur Respir J
, vol.40
, pp. 1106-1114
-
-
Kerwin, E.1
Hebert, J.2
Gallagher, N.3
Martin, C.4
Overend, T.5
Alagappan, V.K.6
-
44
-
-
84872826158
-
Regulation of airway inflammation and remodeling by muscarinic receptors: Perspectives on anticholinergic therapy in asthma and COPD
-
Kistemaker L. Oenema T. Meurs H. Gosens R. (2012) Regulation of airway inflammation and remodeling by muscarinic receptors: Perspectives on anticholinergic therapy in asthma and COPD. Life Sci 91: 1126–1133.
-
(2012)
Life Sci
, vol.91
, pp. 1126-1133
-
-
Kistemaker, L.1
Oenema, T.2
Meurs, H.3
Gosens, R.4
-
45
-
-
0026697298
-
Acetylcholine stimulates bronchial epithelial cells to release neutrophil and monocyte chemotactic activity
-
Koyama S. Rennard S. Robbins R. (1992) Acetylcholine stimulates bronchial epithelial cells to release neutrophil and monocyte chemotactic activity. Am J Physiol 262: L466–L471.
-
(1992)
Am J Physiol
, vol.262
, pp. L466-L471
-
-
Koyama, S.1
Rennard, S.2
Robbins, R.3
-
46
-
-
0031957332
-
Acetylcholine and substance P stimulate bronchial epithelial cells to release eosinophil chemotactic activity
-
Koyama S. Sato E. Nomura H. Kubo K. Nagai S. Izumi T. (1998) Acetylcholine and substance P stimulate bronchial epithelial cells to release eosinophil chemotactic activity. J Appl Physiol 84: 1528–1534.
-
(1998)
J Appl Physiol
, vol.84
, pp. 1528-1534
-
-
Koyama, S.1
Sato, E.2
Nomura, H.3
Kubo, K.4
Nagai, S.5
Izumi, T.6
-
47
-
-
77649272395
-
Role of matrix metalloproteinases in the inflammatory process of respiratory diseases
-
Lagente V. Boichot E. (2010) Role of matrix metalloproteinases in the inflammatory process of respiratory diseases. J Mol Cell Cardiol 48: 440–444.
-
(2010)
J Mol Cell Cardiol
, vol.48
, pp. 440-444
-
-
Lagente, V.1
Boichot, E.2
-
48
-
-
79955838243
-
Aclidinium bromide, a long- acting antimuscarinic, does not affect QT interval in healthy subjects
-
Lasseter K. Aubets J. Chuecos F. Gil E. (2011) Aclidinium bromide, a long- acting antimuscarinic, does not affect QT interval in healthy subjects. J Clin Pharmacol 51: 923–932.
-
(2011)
J Clin Pharmacol
, vol.51
, pp. 923-932
-
-
Lasseter, K.1
Aubets, J.2
Chuecos, F.3
Gil, E.4
-
50
-
-
79952279994
-
Aclidinium bromide improves exercise endurance and lung hyperinflation in patients with moderate to severe COPD
-
Maltais F. Celli B. Casaburi R. Porszasz J. Jarreta D. Seoane B. et al. (2011) Aclidinium bromide improves exercise endurance and lung hyperinflation in patients with moderate to severe COPD. Respir Med 105: 580–587.
-
(2011)
Respir Med
, vol.105
, pp. 580-587
-
-
Maltais, F.1
Celli, B.2
Casaburi, R.3
Porszasz, J.4
Jarreta, D.5
Seoane, B.6
-
55
-
-
77954357471
-
Effect of tiotropium bromide on airway inflammation and remodelling in a mouse model of asthma
-
Ohta S. Oda N. Yokoe T. Tanaka A. Yamamoto Y. Watanabe Y. et al. (2010) Effect of tiotropium bromide on airway inflammation and remodelling in a mouse model of asthma. Clin Exp Allergy 40: 1266–1275.
-
(2010)
Clin Exp Allergy
, vol.40
, pp. 1266-1275
-
-
Ohta, S.1
Oda, N.2
Yokoe, T.3
Tanaka, A.4
Yamamoto, Y.5
Watanabe, Y.6
-
57
-
-
63849193838
-
Additive role of tiotropium in severe asthmatics and Arg16Gly in ADRB 2 as a potential marker to predict response
-
Park H. Yang M. Park C. Kim T. Moon H. Min K. et al. (2009) Additive role of tiotropium in severe asthmatics and Arg16Gly in ADRB 2 as a potential marker to predict response. Allergy 64: 778–783.
-
(2009)
Allergy
, vol.64
, pp. 778-783
-
-
Park, H.1
Yang, M.2
Park, C.3
Kim, T.4
Moon, H.5
Min, K.6
-
58
-
-
80052940501
-
Tiotropium inhibits pulmonary inflammation and remodelling in a guinea pig model of COPD
-
Pera T. Zuidhof A. Valadas J. Smit M. Schoemaker R. Gosens R. et al. (2011) Tiotropium inhibits pulmonary inflammation and remodelling in a guinea pig model of COPD. Eur Respir J 38: 789–796.
-
(2011)
Eur Respir J
, vol.38
, pp. 789-796
-
-
Pera, T.1
Zuidhof, A.2
Valadas, J.3
Smit, M.4
Schoemaker, R.5
Gosens, R.6
-
60
-
-
69049103119
-
Discovery of novel quaternary ammonium derivatives of (3R)-quinuclidinol esters as potent and long-acting muscarinic antagonists with potential for minimal systemic exposure after inhaled administration: identification of (3R)-3-{[hydroxy(di-2-thienyl) acetyl] oxy}-1-(3-phenoxypropyl)-1- azoniabicy clo [2.2.2] octane bromide (aclidinium bromide)
-
Prat M. Fernandez D. Buil M. Crespo M.I. Casals G. Ferrer M. et al. (2009) Discovery of novel quaternary ammonium derivatives of (3R)-quinuclidinol esters as potent and long-acting muscarinic antagonists with potential for minimal systemic exposure after inhaled administration: identification of (3R)-3-{[hydroxy(di-2-thienyl)acetyl] oxy}-1-(3-phenoxypropyl)-1- azoniabicy clo [2.2.2] octane bromide (aclidinium bromide). J Med Chem 52: 5076–5092.
-
(2009)
J Med Chem
, vol.52
, pp. 5076-5092
-
-
Prat, M.1
Fernandez, D.2
Buil, M.3
Crespo, M.I.4
Casals, G.5
Ferrer, M.6
-
61
-
-
79959346315
-
Cigarette smoke extract activates human bronchial epithelial cells affecting non-neuronal cholinergic system signalling in vitro
-
Profita M. Bonanno A. Montalbano A. Ferraro M. Siena L. Bruno A. et al. (2011) Cigarette smoke extract activates human bronchial epithelial cells affecting non-neuronal cholinergic system signalling in vitro. Life Sci 89: 36–43.
-
(2011)
Life Sci
, vol.89
, pp. 36-43
-
-
Profita, M.1
Bonanno, A.2
Montalbano, A.3
Ferraro, M.4
Siena, L.5
Bruno, A.6
-
62
-
-
39149132101
-
Acetylcholine mediates the release of IL-8 in human bronchial epithelial cells by a NFkB/ERK- dependent mechanism
-
Profita M. Bonanno A. Siena L. Ferraro M. Montalbano A. Pompeo F. et al. (2008) Acetylcholine mediates the release of IL-8 in human bronchial epithelial cells by a NFkB/ERK- dependent mechanism. Eur J Pharmacol 582: 145–153.
-
(2008)
Eur J Pharmacol
, vol.582
, pp. 145-153
-
-
Profita, M.1
Bonanno, A.2
Siena, L.3
Ferraro, M.4
Montalbano, A.5
Pompeo, F.6
-
63
-
-
26944437890
-
Muscarinic receptors, leukotriene B 4 production and neutrophilic inflammation in COPD patients
-
Profita M. Giorgi R. Sala A. Bonanno A. Riccobono L. Mirabella F. et al. (2005) Muscarinic receptors, leukotriene B 4 production and neutrophilic inflammation in COPD patients. Allergy 60: 1361–1369.
-
(2005)
Allergy
, vol.60
, pp. 1361-1369
-
-
Profita, M.1
Giorgi, R.2
Sala, A.3
Bonanno, A.4
Riccobono, L.5
Mirabella, F.6
-
64
-
-
2042443069
-
Acetylcholine is an autocrine or paracrine hormone synthesized and secreted by airway bronchial epithelial cells
-
Proskocil B. Sekhon H. Jia Y. Savchenko V. Blakely R. Lindstrom J. et al. (2004) Acetylcholine is an autocrine or paracrine hormone synthesized and secreted by airway bronchial epithelial cells. Endocrinology 145: 2498–2506.
-
(2004)
Endocrinology
, vol.145
, pp. 2498-2506
-
-
Proskocil, B.1
Sekhon, H.2
Jia, Y.3
Savchenko, V.4
Blakely, R.5
Lindstrom, J.6
-
65
-
-
0029793984
-
On muscarinic control of neurogenic mucus secretion in ferret trachea
-
Ramnarine S. Haddad E. Khawaja A. Mak J. Rogers D. (1996) On muscarinic control of neurogenic mucus secretion in ferret trachea. J Physiol 494: 577–586.
-
(1996)
J Physiol
, vol.494
, pp. 577-586
-
-
Ramnarine, S.1
Haddad, E.2
Khawaja, A.3
Mak, J.4
Rogers, D.5
-
67
-
-
0035126934
-
Motor control of airway goblet cells and glands
-
Rogers D. (2001) Motor control of airway goblet cells and glands. Respir Physiol 125: 129–144.
-
(2001)
Respir Physiol
, vol.125
, pp. 129-144
-
-
Rogers, D.1
-
68
-
-
0031778288
-
Acetylcholine stimulates alveolar macrophages to release inflammatory cell chemotactic activity
-
Sato E. Koyama S. Okubo Y. Kubo K. Sekiguchi M. (1998) Acetylcholine stimulates alveolar macrophages to release inflammatory cell chemotactic activity. Am J Physiol 274: L970–L979.
-
(1998)
Am J Physiol
, vol.274
, pp. L970-L979
-
-
Sato, E.1
Koyama, S.2
Okubo, Y.3
Kubo, K.4
Sekiguchi, M.5
-
69
-
-
77950675030
-
Activity of aclidinium bromide, a new long-acting muscarinic antagonist: a phase I study
-
Schelfhout V. Ferrer P. Jansat J. Peris F. Gil E.G. Pauwels R.A. et al. (2010) Activity of aclidinium bromide, a new long-acting muscarinic antagonist: a phase I study. Br J Clin Pharmacol 69: 458–464.
-
(2010)
Br J Clin Pharmacol
, vol.69
, pp. 458-464
-
-
Schelfhout, V.1
Ferrer, P.2
Jansat, J.3
Peris, F.4
Gil, E.G.5
Pauwels, R.A.6
-
70
-
-
77549086503
-
Aclidinium bromide, a new, long- acting, inhaled muscarinic antagonist: in vitro plasma inactivation and pharmacological activity of its main metabolites
-
Sentellas S. Ramos I. Alberti J. Salvà M. Antón F. Miralpeix M. et al. (2010) Aclidinium bromide, a new, long- acting, inhaled muscarinic antagonist: in vitro plasma inactivation and pharmacological activity of its main metabolites. Eur J Pharm Sci 39: 283–290.
-
(2010)
Eur J Pharm Sci
, vol.39
, pp. 283-290
-
-
Sentellas, S.1
Ramos, I.2
Alberti, J.3
Salvà, M.4
Antón, F.5
Miralpeix, M.6
-
71
-
-
84859008802
-
Mortality associated with tiotropium mist inhaler in patients with chronic obstructive pulmonary disease: systematic review and meta-analysis of randomised controlled trials
-
Singh S. Loke Y. Enright P. Furberg C. (2011) Mortality associated with tiotropium mist inhaler in patients with chronic obstructive pulmonary disease: systematic review and meta-analysis of randomised controlled trials. BMJ 342: d3215.
-
(2011)
BMJ
, vol.342
, pp. d3215
-
-
Singh, S.1
Loke, Y.2
Enright, P.3
Furberg, C.4
-
72
-
-
77951134764
-
Remodeling in asthma and COPD - differences and similarities
-
Sköld C. (2010) Remodeling in asthma and COPD - differences and similarities. Clin Respir J 4(Suppl. 1): 20–27.
-
(2010)
Clin Respir J
, vol.4
, pp. 20-27
-
-
Sköld, C.1
-
73
-
-
69549098265
-
Exploring the mechanism of agonist efficacy: a relationship between efficacy and agonist dissociation rate at the muscarinic M 3 receptor
-
Sykes D. Dowling M. Charlton S. (2009) Exploring the mechanism of agonist efficacy: a relationship between efficacy and agonist dissociation rate at the muscarinic M 3 receptor. Mol Pharmacol 76: 543–551.
-
(2009)
Mol Pharmacol
, vol.76
, pp. 543-551
-
-
Sykes, D.1
Dowling, M.2
Charlton, S.3
-
74
-
-
53749102775
-
for the UPLIFT Study Investigators
-
A 4-year trial of tiotropium in chronic obstructive pulmonary disease
-
Tashkin D. Celli B. Senn S. Burkhart D. Kesten S. Menjoge S. et al. for the UPLIFT Study Investigators (2008) A 4-year trial of tiotropium in chronic obstructive pulmonary disease. N Engl J Med 359: 1543–1554.
-
(2008)
N Engl J Med
, vol.359
, pp. 1543-1554
-
-
Tashkin, D.1
Celli, B.2
Senn, S.3
Burkhart, D.4
Kesten, S.5
Menjoge, S.6
-
75
-
-
84872231976
-
Once-daily glycopyrronium bromide, a long-acting muscarinic antagonist, for chronic obstructive pulmonary disease: a systematic review of clinical benefit
-
Ulrik C. (2012) Once-daily glycopyrronium bromide, a long-acting muscarinic antagonist, for chronic obstructive pulmonary disease: a systematic review of clinical benefit. Int J COPD 7: 673–678.
-
(2012)
Int J COPD
, vol.7
, pp. 673-678
-
-
Ulrik, C.1
-
76
-
-
79951951764
-
Inhibition of granulocyte migration by tiotropium bromide
-
Vacca G. Randerath W. Gillissen A. (2011) Inhibition of granulocyte migration by tiotropium bromide. Respir Res 12: 24.
-
(2011)
Respir Res
, vol.12
, pp. 24
-
-
Vacca, G.1
Randerath, W.2
Gillissen, A.3
-
77
-
-
77956957659
-
Onset of effect of aclidinium, a novel long-acting muscarinic antagonist, in patients with COPD
-
Vestbo J. Vogelmeier C. Creemers J. Faiques M. Ribera A. Gil E. (2010) Onset of effect of aclidinium, a novel long-acting muscarinic antagonist, in patients with COPD. COPD 7: 331–336.
-
(2010)
COPD
, vol.7
, pp. 331-336
-
-
Vestbo, J.1
Vogelmeier, C.2
Creemers, J.3
Faiques, M.4
Ribera, A.5
Gil, E.6
-
78
-
-
79957802503
-
NVA237, a long-acting muscarinic antagonist, as an emerging therapy for chronic obstructive pulmonary disease
-
Vogelmeier C. Banerji D. (2011) NVA237, a long-acting muscarinic antagonist, as an emerging therapy for chronic obstructive pulmonary disease. Ther Adv Respir Dis 5: 163–173.
-
(2011)
Ther Adv Respir Dis
, vol.5
, pp. 163-173
-
-
Vogelmeier, C.1
Banerji, D.2
-
79
-
-
60249095813
-
Mucins, mucus, and sputum
-
Voynow J. Rubin B. (2009) Mucins, mucus, and sputum. Chest 135: 505–512.
-
(2009)
Chest
, vol.135
, pp. 505-512
-
-
Voynow, J.1
Rubin, B.2
-
80
-
-
49449094458
-
Acetylcholine beyond neurons: the non-neuronal cholinergic system in humans
-
Wessler I. Kirkpatrick C. (2008) Acetylcholine beyond neurons: the non-neuronal cholinergic system in humans. Br J Pharmacol 154: 1558–1571.
-
(2008)
Br J Pharmacol
, vol.154
, pp. 1558-1571
-
-
Wessler, I.1
Kirkpatrick, C.2
-
81
-
-
84885734407
-
for the TIOSPIR Investigators
-
Tiotropium Respimat inhaler and the risk of death in COPD
-
Wise R. Anzueto A. Cotton D. Dahl R. Devins T. Disse B. et al. for the TIOSPIR Investigators (2013) Tiotropium Respimat inhaler and the risk of death in COPD. N Engl J Med 369: 1491–1501.
-
(2013)
N Engl J Med
, vol.369
, pp. 1491-1501
-
-
Wise, R.1
Anzueto, A.2
Cotton, D.3
Dahl, R.4
Devins, T.5
Disse, B.6
-
82
-
-
77953123408
-
Tiotropium bromide exerts anti-inflammatory activity in a cigarette smoke mouse model of COPD
-
Wollin L. Pieper M. (2010) Tiotropium bromide exerts anti-inflammatory activity in a cigarette smoke mouse model of COPD. Pulm Pharmacol Ther 23: 345–354.
-
(2010)
Pulm Pharmacol Ther
, vol.23
, pp. 345-354
-
-
Wollin, L.1
Pieper, M.2
-
83
-
-
79955664791
-
Tiotropium for treatment of stable COPD: a meta-analysis of clinically relevant outcomes
-
Yohannes A. Willgoss T. Vestbo J. (2011) Tiotropium for treatment of stable COPD: a meta-analysis of clinically relevant outcomes. Respir Care 56: 477–487.
-
(2011)
Respir Care
, vol.56
, pp. 477-487
-
-
Yohannes, A.1
Willgoss, T.2
Vestbo, J.3
|